뒤로
Adagene Inc(ADAG) 가격
ADAG 주가 차트
ADAG 수입
Adagene Inc
$1.96
2.08%
$0.04
종가: Jan 16, 16:00:00 GMT-5
$1.98
1.24%
$0.02
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$1.92
시가
$1.88
일일 범위
$1.88 - $1.98
52주 범위
$1.3 - $3.16
거래량
53.8K
평균 거래량
119.9K
EPS(TTM)
-0.51
배당수익률
--
시가총액
$93.4M
ADAG란 무엇인가요?
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. The company is headquartered in Suzhou, Jiangsu and currently employs 138 full-time employees. The company went IPO on 2021-02-09. The firm is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.